TerrAscend Corp.

TSND

CA88105E1088

Drug Retailers

Delayed Toronto S.E. Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
2.46 ^CAD	+0.82%		+8.37%	+11.82%

May. 09	Transcript : TerrAscend Corp., Q1 2024 Earnings Call, May 09, 2024
May. 09	TerrAscend Brief: Q1 Net Revenue of US$80.6 million, an increase of 16.1% year-over-year; Cash Flow from operations of $13.3 million and Free Cash Flow of $10.5 million in the quarter	MT

TerrAscend Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 09, 2024 at 04:05 pm EDT

TerrAscend Corp. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 80.63 million compared to USD 69.4 million a year ago.

Net loss was USD 17.06 million compared to USD 24.96 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to USD 0.08 a year ago.

Basic loss per share was USD 0.06 compared to USD 0.09 a year ago. Diluted loss per share was USD 0.06 compared to USD 0.09 a year ago.

Latest news about TerrAscend Corp.

Transcript : TerrAscend Corp., Q1 2024 Earnings Call, May 09, 2024	May. 09
TerrAscend Brief: Q1 Net Revenue of US$80.6 million, an increase of 16.1% year-over-year; Cash Flow from operations of $13.3 million and Free Cash Flow of $10.5 million in the quarter	May. 09	MT
Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M	May. 09	MT
TerrAscend Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey	Apr. 24	CI
Transcript : TerrAscend Corp., 2023 Earnings Call, Mar 14, 2024	Mar. 14
TerrAscend Fourth-Quarter Loss Widens as Sales Rise by 26%	Mar. 14	MT
TerrAscend Brief: Q4 Net loss from continuing operations US$41.8 Million	Mar. 14	MT
TerrAscend Brief: Q4 Net Revenue was US$86.6 million, an increase of 25.5% year-over-year	Mar. 14	MT
TerrAscend Corp. Reports Impairment Charges for the Three Months Ended December 31, 2023	Mar. 14	CI
TerrAscend Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
North American Morning Briefing : Stock Futures Rise Ahead of PPI Data	Mar. 14	DJ
TerrAscend Announcing Expansion of its Valhalla Product Offering	Jan. 24	MT
TerrAscend Brief: Announcing expansion of its Valhalla product offering	Jan. 24	MT
TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone State	Jan. 24	CI
Transcript : TerrAscend Corp., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
TerrAscend Corp. Raises Earnings Guidance for 2023	Nov. 09	CI
Earnings Flash (TSND) TERRASCEND Reports Q3 Net Revenue $89.2M	Nov. 09	MT
Earnings Flash (TSND) TERRASCEND Posts Q3 Revenue $89.2M	Nov. 09	MT
TerrAscend Brief: Raising Full Year 2023 Guidance	Nov. 09	MT
TerrAscend Brief: Q3 Net Revenue of US$89.2 million, an increase of 34.7% year-over-year and 23.7% sequentially	Nov. 09	MT
TerrAscend Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
North American Morning Briefing : Traders Await -2-	Nov. 09	DJ
TerrAscend Corp. acquired Four high-performing retail dispensaries in Maryland for $0.01 million.	Nov. 08	CI
TerrAscend Seeks Acquisitions	23-10-13	CI

Chart TerrAscend Corp.

Duration

Period

More charts

Company Profile

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. It also operates Peninsula Alternative Health, a medical dispensary in Maryland. The Company owns or licenses several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. Ilera Healthcare is a medical cannabis cultivator, processor and dispenser with operations in New Jersey. Valhalla Confections is a manufacturer of cannabis-infused edibles.

Sector

Drug Retailers

Calendar

2024-05-23 - CG Global Cannabis Conference - Panel

More about the company

Income Statement Evolution

More financial data

Ratings for TerrAscend Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.808 USD

Average target price

3.083 USD

Spread / Average Target

+70.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cannabis Product Retailers

	1st Jan change	Capi.
TERRASCEND CORP.	+11.82%	527M
GREEN THUMB INDUSTRIES INC.	+18.70%	3.08B
VERANO HOLDINGS CORP.	+18.71%	1.77B
GLASS HOUSE BRANDS INC.	+98.73%	678M
HIGH TIDE INC.	+40.38%	174M
CANTOURAGE GROUP SE	-2.51%	98.29M
MARIMED INC.	-9.35%	95.52M
GOLD FLORA CORPORATION	+46.88%	67.59M
NOVA CANNABIS INC.	+40.45%	57.04M

Cannabis Product Retailers

TerrAscend Corp.

Equities

TSND

CA88105E1088

Drug Retailers

TerrAscend Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024

EPS Revisions